References
- Castleman B, Iverson L, Menendez VP. Localized mediastinal lymph-node hyperplasia resembling thymoma. Cancer 1956; 9: 822–30.
- Keller AR, Hochholzer L, Castleman. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer 1972; 29: 670–83.
- Bowne WB, Lewis JJ, Filippa DA, et al. The management of unicentric and multicentric CD. A report of 16 cases and review of the literature. Cancer 1999; 85: 706–17.
- Larroche C, Cacoub P, Soulier J, et al. Castleman's disease and lymphoma: report of eight cases in HIV-negative patients and literature review Am J Hematol 2002; 69: 119–26.
- Ming-Qing D, Liu H, Diss TC, et al. Kaposi sarcoma-associated herpesvirus infects monotypic (IgM) but polyclonal naive B-cells in Castleman disease and associated lymphopro-liferative disorders. Blood 2001; 97: 2130–6.
- Oksenhendler E, Carcelain G, Aoki Y, et al. High levels of human herpesvirus 8 viral load, human IL-6, IL-10, and C-reactive disease in HIV-infected patients. Blood 2000; 96: 2069–73.
- Chronowski GM, Ha CS, Wilder RB, Cabanillas F, Manning J, Cox JD. Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy. Cancer 2001; 92: 670–6.
- Beck JT, Hsu SM, Wijdenes J, et al. Alleviation of systemic manifestations of CD by monoclonal anti-interleukin-6 anti-body. Neth J M 1994; 330: 602–5.
- Bordeleau L, Bredeson C, Markman S. 2-chloro-deoxyadeno-sine therapy for giant lymphnode hyperplasia. Br J Haematol 1995; 91: 668–70.
- Corbellino M, Bestetti G, Scalamogna C, et al. Long-term remission of Kaposi sarcoma-associated herpesvirus-related multicentric Castleman disease with anti-CD20 monoclonal antibody therapy. Blood 2001; 98: 3473–5.
- Fisher RI, Gaynor ER, Dhalberg S, et al. Comparison of standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med 1993; 328: 1002–6.
- Rodriguez MA, Cabanillas FC, Velasquez W, Hagemeister FB, McLaughlin P, Swan F, Romanguera. Results of salvage treatment program for relapsing lymphoma: MINE consoli-dated with ESHAP. J Clin Oncol 1995; 13: 1734–41.
- Weisenburger DD, Nathawani BN,Winberg CD, Rappaport H. Multicentric angiofollicular lymph node hyperplasia: a clinicopathologic study of 16 cases. Hum Pathol 1985; 16: 16-72.
- Weiss GR, Kuhn JG, Rizzo J, 3rd, Fields S, VanDenBerg K, von Hoff DD. A phase I and pharmacokinetics study of 2- chlorodeoxyadenosine in patients with solid tumors. Cancer Chemother Pharmacol 1995; 35: 397-402.
- Van Den Neste E, Delannoy A, Feremans W, Ferrant A, Michaux L. Second primary tumors and immune phenomena after fludarabine or 2-chloro-2?-deoxyadenosine treatment. Leuk Lymphoma 2001; 40: 541-50.
- Robak T, Urbanska-Rys H, Strzelecka B, et al. Plasmablastic lymphoma in a patient with chronic lymphocytic leukemia heavily pretreated with cladribine (2-CdA): an unusual variant of Richter�s syndrome. Eur J Haematol 2001; 67: 322-7.